Molecular characterization of the craniosynostosis-associated interleukin-11 receptor variants p.T306_S308dup and p.E364_V368del.
SNP
craniosynostosis
gp130
interleukin-11
interleukin-11 receptor
Journal
The FEBS journal
ISSN: 1742-4658
Titre abrégé: FEBS J
Pays: England
ID NLM: 101229646
Informations de publication
Date de publication:
22 Nov 2023
22 Nov 2023
Historique:
revised:
02
11
2023
received:
08
09
2023
accepted:
21
11
2023
pubmed:
23
11
2023
medline:
23
11
2023
entrez:
23
11
2023
Statut:
aheadofprint
Résumé
Interleukin-11 (IL-11) is a member of the IL-6 family of cytokines and is an important factor for bone homeostasis. IL-11 binds to and signals via the membrane-bound IL-11 receptor (IL-11R, classic signaling) or soluble forms of the IL-11R (sIL-11R, trans-signaling). Mutations in the IL11RA gene, which encodes the IL-11R, are associated with craniosynostosis, a human condition in which one or several of the sutures close prematurely, resulting in malformation of the skull. The biological mechanisms of how mutations within the IL-11R are linked to craniosynostosis are mostly unexplored. In this study, we analyze two variants of the IL-11R described in craniosynostosis patients: p.T306_S308dup, which results in a duplication of three amino-acid residues within the membrane-proximal fibronectin type III domain, and p.E364_V368del, which results in a deletion of five amino-acid residues in the so-called stalk region adjacent to the plasma membrane. The stalk region connects the three extracellular domains to the transmembrane and intracellular region of the IL-11R and contains cleavage sites for different proteases that generate sIL-11R variants. Using a combination of bioinformatics and different biochemical, molecular, and cell biology methods, we show that the IL-11R-T306_S308dup variant does not mature correctly, is intracellularly retained, and does not reach the cell surface. In contrast, the IL-11R-E364_V368del variant is fully biologically active and processed normally by proteases, thus allowing classic and trans-signaling of IL-11. Our results provide evidence that mutations within the IL11RA gene may not be causative for craniosynostosis and suggest that other regulatory mechanism(s) are involved but remain to be identified.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : 125440785-SFB877-A10
Informations de copyright
© 2023 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.
Références
Garbers C, Hermanns H, Schaper F, Müller-Newen G, Grötzinger J, Rose-John S & Scheller J (2012) Plasticity and cross-talk of interleukin 6-type cytokines. Cytokine Growth Factor Rev 23, 85-97.
Ernst M, Najdovska M, Grail D, Lundgren-May T, Buchert M, Tye H, Matthews V, Armes J, Bhathal P, Hughes N et al. (2008) STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest 118, 1727-1738.
Balic JJ, Garbers C, Rose-John S, Yu L & Jenkins BJ (2017) Interleukin-11-driven gastric tumourigenesis is independent of trans-signalling. Cytokine 92, 118-123.
Putoczki T, Thiem S, Loving A, Busuttil R, Wilson N, Ziegler P, Nguyen P, Preaudet A, Farid R, Edwards K et al. (2013) Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically. Cancer Cell 24, 257-271.
Johnstone CN, Chand A, Putoczki TL & Ernst M (2015) Emerging roles for IL-11 signaling in cancer development and progression: focus on breast cancer. Cytokine Growth Factor Rev 26, 489-498.
Winship AL, Van Sinderen M, Donoghue J, Rainczuk K & Dimitriadis E (2016) Targeting interleukin-11 receptor-α impairs human endometrial cancer cell proliferation and invasion in vitro and reduces tumour growth and metastasis in vivo. Mol Cancer Ther 15, 720-730.
Schleinkofer K, Dingley A, Tacken I, Federwisch M, Muller-Newen G, Heinrich PC, Vusio P, Jacques Y & Grotzinger J (2001) Identification of the domain in the human interleukin-11 receptor that mediates ligand binding. J Mol Biol 306, 263-274.
Nitz R, Lokau J, Aparicio-Siegmund S, Scheller J & Garbers C (2015) Modular organization of Interleukin-6 and Interleukin-11 α-receptors. Biochimie 119, 175-182.
Monhasery N, Moll J, Cuman C, Franke M, Lamertz L, Nitz R, Gorg B, Häussinger D, Lokau J, Floss DM et al. (2016) Transcytosis of IL-11 and apical redirection of gp130 is mediated by IL-11alpha receptor. Cell Rep 16, 1067-1081.
Hilton DJ, Hilton AA, Raicevic A, Rakar S, Harrison-Smith M, Gough NM, Begley CG, Metcalf D, Nicola NA & Willson TA (1994) Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J 13, 4765-4775.
Yin T, Taga T, Tsang ML, Yasukawa K, Kishimoto T & Yang YC (1993) Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction. J Immunol 151, 2555-2561.
Koch L, Kespohl B, Agthe M, Schumertl T, Düsterhöft S, Lemberg MK, Lokau J & Garbers C (2021) Interleukin-11 (IL-11) receptor cleavage by the rhomboid protease RHBDL2 induces IL-11 trans-signaling. FASEB J 35, e21380.
Lokau J, Agthe M, Flynn CM & Garbers C (2017) Proteolytic control of Interleukin-11 and Interleukin-6 biology. Biochim Biophys Acta 1864, 2105-2117.
Lokau J, Nitz R, Agthe M, Monhasery N, Aparicio-Siegmund S, Schumacher N, Wolf J, Möller-Hackbarth K, Waetzig GH, Grötzinger J et al. (2016) Proteolytic cleavage governs interleukin-11 trans-signaling. Cell Rep 14, 1761-1773.
Sammel M, Peters F, Lokau J, Scharfenberg F, Werny L, Linder S, Garbers C, Rose-John S & Becker-Pauly C (2019) Differences in shedding of the interleukin-11 receptor by the proteases ADAM9, ADAM10, ADAM17, meprin alpha, meprin beta and MT1-MMP. Int J Mol Sci 20, 3677.
Schreiber S, Aden K, Bernardes JP, Conrad C, Tran F, Hoper H, Volk V, Mishra N, Blase JI, Nikolaus S et al. (2021) Therapeutic IL-6 trans-signalling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease. Gastroenterology 160, 2354-2366.e11.
Zhang S, Chen B, Wang B, Chen H, Li Y, Cao Q, Zhong J, Shieh MJ, Ran Z, Tang T et al. (2023) Effect of induction therapy with Olamkicept vs placebo on clinical response in patients with active ulcerative colitis: a randomized clinical trial. JAMA 329, 725-734.
Lokau J, Garbers Y, Grotzinger J & Garbers C (2021) A single aromatic residue in sgp130Fc/olamkicept allows the discrimination between interleukin-6 and interleukin-11 trans-signaling. iScience 24, 103309.
Lokau J, Wandel M & Garbers C (2017) Enhancing Interleukin-6 and Interleukin-11 receptor cleavage. Int J Biochem Cell Biol 85, 6-14.
Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, Burgess S, Jiang T, Paige E, Surendran P et al. (2018) Genomic atlas of the human plasma proteome. Nature 558, 73-79.
Agthe M, Garbers Y, Putoczki T & Garbers C (2017) Interleukin-11 classic but not trans-signaling is essential for fertility in mice. Placenta 57, 13-16.
Robb L, Li R, Hartley L, Nandurkar HH, Koentgen F & Begley GC (1998) Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation. Nat Med 4, 303-308.
Bilinski P, Roopenian D & Gossler A (1998) Maternal IL-11Ralpha function is required for normal decidua and fetoplacental development in mice. Genes Dev 12, 2234-2243.
Kespohl B, Schumertl T, Bertrand J, Lokau J & Garbers C (2021) The cytokine interleukin-11 crucially links bone formation, remodeling and resorption. Cytokine Growth Factor Rev 60, 18-27.
Lokau J, Göttert S, Arnold P, Düsterhöft S, Massa Lopez D, Grötzinger J & Garbers C (2017) The SNP rs4252548 (R112H) which is associated with reduced human height compromises the stability of IL-11. Biochim Biophys Acta 1865, 496-506.
Marouli E, Graff M, Medina-Gomez C, Lo KS, Wood AR, Kjaer TR, Fine RS, Lu Y, Schurmann C, Highland HM et al. (2017) Rare and low-frequency coding variants alter human adult height. Nature 542, 186-190.
Lanktree MB, Guo Y, Murtaza M, Glessner JT, Bailey SD, Onland-Moret CN, Lettre G, Ongen H, Rajagopalan R, Johnson T et al. (2011) Meta-analysis of dense Genecentric association studies reveals common and uncommon variants associated with height. Am J Hum Genet 88, 6-18.
Keupp K, Li Y, Vargel I, Hoischen A, Richardson R, Neveling K, Alanay Y, Uz E, Elcioğlu N, Rachwalski M et al. (2013) Mutations in the interleukin receptor IL11RA cause autosomal recessive Crouzon-like craniosynostosis. Mol Genet Genomic Med 1, 223-237.
Nieminen P, Morgan N, Fenwick A, Parmanen S, Veistinen L, Mikkola M, van der Spek P, Giraud A, Judd L, Arte S et al. (2011) Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth. Am J Hum Genet 89, 67-81.
Korakavi N, Prokop JW & Seaver LH (2019) Evolution of the phenotype of craniosynostosis with dental anomalies syndrome and report of IL11RA variant population frequencies in a Crouzon-like autosomal recessive syndrome. Am J Med Genet A 179, 668-673.
Brischoux-Boucher E, Trimouille A, Baujat G, Goldenberg A, Schaefer E, Guichard B, Hannequin P, Paternoster G, Baer S, Cabrol C et al. (2018) IL11RA-related Crouzon-like autosomal recessive craniosynostosis in 10 new patients: resemblances and differences. Clin Genet 94, 373-380.
Clarke CM, Fok VT, Gustafson JA, Smyth MD, Timms AE, Frazar CD, Smith JD, Birgfeld CB, Lee A, Ellenbogen RG et al. (2018) Single suture craniosynostosis: identification of rare variants in genes associated with syndromic forms. Am J Med Genet A 176, 290-300.
Teven CM, Farina EM, Rivas J & Reid RR (2014) Fibroblast growth factor (FGF) signaling in development and skeletal diseases. Genes Dis 1, 199-213.
Passos-Bueno M, Sertie Eacute A, Jehee F, Fanganiello R & Yeh E (2008) Genetics of craniosynostosis: genes, syndromes, mutations and genotype-phenotype correlations. Front Oral Biol 12, 107-143.
Sims NA, Jenkins BJ, Nakamura A, Quinn JM, Li R, Gillespie MT, Ernst M, Robb L & Martin TJ (2005) Interleukin-11 receptor signaling is required for normal bone remodeling. J Bone Miner Res 20, 1093-1102.
Agthe M, Brugge J, Garbers Y, Wandel M, Kespohl B, Arnold P, Flynn CM, Lokau J, Aparicio-Siegmund S, Bretscher C et al. (2018) Mutations in craniosynostosis patients cause defective interleukin-11 receptor maturation and drive craniosynostosis-like disease in mice. Cell Rep 25, 10-18.e5.
Ahmad I, Lokau J, Kespohl B, Malik NA, Baig SM, Hartig R, Behme D, Schwab R, Altmuller J, Jameel M et al. (2023) The interleukin-11 receptor variant p.W307R results in craniosynostosis in humans. Sci Rep 13, 13479.
Agthe M, Garbers Y, Grötzinger J & Garbers C (2018) Two N-linked glycans differentially control maturation, trafficking and proteolysis, but not activity of the IL-11 receptor. Cell Physiol Biochem 45, 2071-2085.
Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alfoldi J, Wang Q, Collins RL, Laricchia KM, Ganna A, Birnbaum DP et al. (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434-443.
Kespohl B, Hartig R, Garbers Y, Lokau J & Garbers C (2022) Coding variants of the interleukin-11 receptor with reduced protein maturation show protease-dependent trans-signaling and transduce normal STAT3 signaling. Genes Dis 10, 373-376.
Olsen JG & Kragelund BB (2014) Who climbs the tryptophan ladder? On the structure and function of the WSXWS motif in cytokine receptors and thrombospondin repeats. Cytokine Growth Factor Rev 25, 337-341.
Dagil R, Knudsen MJ, Olsen JG, O'Shea C, Franzmann M, Goffin V, Teilum K, Breinholt J & Kragelund BB (2012) The WSXWS motif in cytokine receptors is a molecular switch involved in receptor activation: insight from structures of the prolactin receptor. Structure 20, 270-282.
Siupka P, Hamming OT, Kang L, Gad HH & Hartmann R (2015) A conserved sugar bridge connected to the WSXWS motif has an important role for transport of IL-21R to the plasma membrane. Genes Immun 16, 405-413.
Shcherbakova A, Preller M, Taft MH, Pujols J, Ventura S, Tiemann B, Buettner FF & Bakker H (2019) C-mannosylation supports folding and enhances stability of thrombospondin repeats. Elife 8, e52978.
Shcherbakova A, Tiemann B, Buettner FF & Bakker H (2017) Distinct C-mannosylation of netrin receptor thrombospondin type 1 repeats by mammalian DPY19L1 and DPY19L3. Proc Natl Acad Sci USA 114, 2574-2579.
Mirdita M, Schutze K, Moriwaki Y, Heo L, Ovchinnikov S & Steinegger M (2022) ColabFold: making protein folding accessible to all. Nat Methods 19, 679-682.
Baek M, DiMaio F, Anishchenko I, Dauparas J, Ovchinnikov S, Lee GR, Wang J, Cong Q, Kinch LN, Schaeffer RD et al. (2021) Accurate prediction of protein structures and interactions using a three-track neural network. Science 373, 871-876.
Lokau J & Garbers C (2018) The length of the interleukin-11 receptor stalk determines its capacity for classic signaling. J Biol Chem 293, 6398-6409.
Mun DG, Bhin J, Kim S, Kim H, Jung JH, Jung Y, Jang YE, Park JM, Kim H, Jung Y et al. (2019) Proteogenomic characterization of human early-onset gastric cancer. Cancer Cell 35, e10.
Zhang Y, Zhang K, Bu F, Hao P, Yang H, Liu S & Ren Y (2020) D283 med, a cell line derived from peritoneal metastatic Medulloblastoma: a good choice for missing protein discovery. J Proteome Res 19, 4857-4866.
Lokau J, Kespohl B, Kirschke S & Garbers C (2022) The role of proteolysis in interleukin-11 signaling. Biochim Biophys Acta Mol Cell Res 1869, 119135.
Lokau J, Agthe M & Garbers C (2016) Generation of soluble Interleukin-11 and Interleukin-6 receptors: a crucial function for proteases during inflammation. Mediators Inflamm 2016, 1785021.
Sun Z & Brodsky JL (2019) Protein quality control in the secretory pathway. J Cell Biol 218, 3171-3187.
Xu C & Ng DTW (2015) Glycosylation-directed quality control of protein folding. Nat Rev Mol Cell Biol 16, 742-752.
Araki K & Nagata K (2011) Protein folding and quality control in the ER. Cold Spring Harb Perspect Biol 3, a007526.
Tucher J, Linke D, Koudelka T, Cassidy L, Tredup C, Wichert R, Pietrzik C, Becker-Pauly C & Tholey A (2014) LC-MS based cleavage site profiling of the proteases ADAM10 and ADAM17 using proteome-derived peptide libraries. J Proteome Res 13, 2205-2214.
Caescu C, Jeschke G & Turk B (2009) Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10. Biochem J 424, 79-88.
Topa A, Rohlin A, Andersson MK, Fehr A, Lovmar L, Stenman G & Kolby L (2022) The outcome of targeted NGS screening in patients with syndromic forms of sagittal and pansynostosis - IL11RA is an emerging core-gene for pansynostosis. Eur J Med Genet 65, 104476.
Fischer M, Goldschmitt J, Peschel C, Brakenhoff JP, Kallen KJ, Wollmer A, Grötzinger J & Rose-John S (1997) I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat Biotechnol 15, 142-145.
Adrain C, Strisovsky K, Zettl M, Hu L, Lemberg M & Freeman M (2011) Mammalian EGF receptor activation by the rhomboid protease RHBDL2. EMBO Rep 12, 421-427.
Metcalfe RD, Aizel K, Zlatic CO, Nguyen PM, Morton CJ, Lio DS, Cheng HC, Dobson RCJ, Parker MW, Gooley PR et al. (2020) The structure of the extracellular domains of human interleukin 11alpha receptor reveals mechanisms of cytokine engagement. J Biol Chem 295, 8285-8301.
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC & Ferrin TE (2004) UCSF chimera-a visualization system for exploratory research and analysis. J Comput Chem 25, 1605-1612.
Pettersen EF, Goddard TD, Huang CC, Meng EC, Couch GS, Croll TI, Morris JH & Ferrin TE (2021) UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci 30, 70-82.
Deutsch EW (2010) The PeptideAtlas project. Methods Mol Biol 604, 285-296.
Geiszler DJ, Polasky DA, Yu F & Nesvizhskii AI (2023) Detecting diagnostic features in MS/MS spectra of post-translationally modified peptides. Nat Commun 14, 4132.